Trotana Therapeutics

Trotana, Inc.

San Diego, United States · $52.5M raised

Headquarters
San Diego
Employees
11–50
Business Model
B2B
Total Funding
$52.5M
Last Round
$52.5M Series AFeb 2025
Rounds
1

About

Trotana Therapeutics is a San Diego-based biotechnology company developing RNA-based therapies and novel oral anti-inflammatory medicines, pursuing precision treatments for chronic inflammatory disease. The company closed a $52.5 million Series A financing (announced by investor Lightstone Ventures in early 2025) to fund its translational biology and medicinal chemistry programs and advance its pipeline toward human clinical trials. Trotana, Inc. operates as a privately held, venture-backed drug discovery company with a small, specialized research team.

Summary

Trotana Therapeutics is a Biotech company based in San Diego, United States. It has raised $52.5M in total across 1 round, most recently a $52.5M Series A round in Feb 2025. Investors include Lightstone Ventures, ARCH Venture Partners and Andreessen Horowitz.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2025
$52.5M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trotana Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/trotana-therapeutics"><img src="https://indexed.vc/api/badge/company/trotana-therapeutics" alt="Trotana Therapeutics on Indexed.vc" width="260" height="76" /></a>